The complement SC5b-9 complex mediates cell adhesion through a vitronectin receptor.
Adhesion of cells to the terminal complement complex of C5b through C9 containing the serum S-protein (SC5b-9) was investigated using a microtiter plate attachment assay with L8 myoblast indicator cells. The skeletal muscle-derived L8 myoblasts bound and spread on substratum coated with SC5b-9, and with the vitronectin/S-protein component of SC5b-9. The myoblasts did not adhere to substratum coated with collagen, laminin, or fibronectin. The cell attachment was blocked by antibody to vitronectin/S-protein, whereas antibody to the other components C5, C6, C7, C8, or C9 had minimal effect. The cells were not bound to free vitronectin because attachment activity was removed by adsorption with an anti-C6 antibody column. The L8 cell attachment was dependent on divalent cations, was blocked by synthetic peptides containing the amino acid sequence Arg-Gly-Asp, and was inhibited by antivitronectin receptor antibody. These results indicate that cells adhere to the SC5b-9 complex through interaction of the vitronectin component with an integrin vitronectin receptor. Cell attachment to terminal C complexes could be used for leukocyte adherence and migration during inflammation, and also for attachment of tissue cells during regeneration after disease or traumatic injury.
Department of Pathology, Hahnemann University, Philadelphia, PA 19102.
G
G
Biesecker
D000818:Animals; D001665:Binding Sites; D002413:Cations, Divalent / Q000378:metabolism; D002448:Cell Adhesion; D003078:Colchicine / Q000494:pharmacology; D015938:Complement Membrane Attack Complex; D003165:Complement System Proteins / Q000378:metabolism*; D003572:Cytochalasins / Q000494:pharmacology; D004492:Edetic Acid / Q000494:pharmacology; D006023:Glycoproteins / Q000378:metabolism*; D007158:Immunologic Techniques; D066298:In Vitro Techniques; D016023:Integrins / Q000378:metabolism*; D051381:Rats; D011971:Receptors, Immunologic / Q000378:metabolism*; D019030:Receptors, Vitronectin; D019096:Vitronectin
D002413:Cations, Divalent; D015938:Complement Membrane Attack Complex; D003572:Cytochalasins; D006023:Glycoproteins; D016023:Integrins; D011971:Receptors, Immunologic; D019030:Receptors, Vitronectin; C047610:SC5b-9 protein complex; D019096:Vitronectin; D003165:Complement System Proteins; D004492:Edetic Acid; D003078:Colchicine